2010 Publications

Publications resulting from human brain tissue obtained from the ABBN.

Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, and Trojanowski JQ. (2010) Olfactory epithelium amyloid-β and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol. 67: 462-469.

Ballatore C, Brunden KR, Piscitelli F, James MJ, Crowe A, Yao Y, Hyde E, Trojanowski JQ, Lee VM, and Smith AB, 3rd. (2010) Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation. J Med Chem. 53: 3739-3747.

Banerjee K, Sinha M, Pham Cle L, Jana S, Chanda D, Cappai R, and Chakrabarti S. (2010) α-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS Lett. 584: 1571-1576.

Barakat A, Dean B, Scarr E, and Evin G. (2010) Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Schizophr Res. 124: 200-207.

Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, and Cairns MJ. (2010) Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry. 15: 1176-1189.

Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, Blumbergs PC, Vucic S, Kiernan MC, and Nicholson GA. (2010) FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry. 81: 639-645.

Boer S, Sanchez D, Reinieren I, van den Boom T, Udawela M, Scarr E, Ganfornina MD, and Dean B. (2010) Decreased kainate receptors in the hippocampus of apolipoprotein D knockout mice. Prog Neuropsychopharmacol Biol Psychiatry. 34: 271-278.

Boon WC, van den Buuse M, Wegener N, Martin S, Chua HK, Bush AI, Masters CL, Adlard PA, and Li QX. (2010) Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Aβ-bearing fragment is associated with reduced NMDA receptor density. Behav Brain Res. 209: 27-35.

Brunden KR, Ballatore C, Crowe A, Smith AB, 3rd, Lee VM, and Trojanowski JQ. (2010) Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol. 223: 304-310.

Byrne GJ, Pachana NA, Goncalves DC, Arnold E, King R, and Khoo SK. (2010) Psychometric properties and health correlates of the Geriatric Anxiety Inventory in Australian community-residing older women. Aging Ment Health. 14: 247-254.

Cairns NJ, Taylor-Reinwald L, and Morris JC. (2010) Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core. Alzheimers Dement. 6: 274-279.

Caragounis A, Price KA, Soon CP, Filiz G, Masters CL, Li QX, Crouch PJ, and White AR. (2010) Zinc induces depletion and aggregation of endogenous TDP-43. Free Radic Biol Med. 48: 1152-1161.

Chavez C, Hollaus M, Scarr E, Pavey G, Gogos A, and van den Buuse M. (2010) The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain research. 1321: 51-59.

Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, Grant R, Brew BJ, and Guillemin GJ. (2010) The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox Res. 18: 132-142.

Chen-Plotkin AS, Lee VM, and Trojanowski JQ. (2010) TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 6: 211-220.

Chetelat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, and Rowe CC. (2010) Relationship between atrophy and β-amyloid deposition in Alzheimer disease. Ann Neurol. 67: 317-324.

Collins SJ, Schuur M, Boyd A, Lewis V, Klug GM, McGlade A, van Oosterhout A, Breedveld G, Oostra BA, Masters C, and Van Duijn CM. (2010) No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease. Neurosci Lett. 472: 16-18.

Corben LA, Delatycki MB, Bradshaw JL, Horne MK, Fahey MC, Churchyard AJ, and Georgiou-Karistianis N. (2010) Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction. J Neurol. 257: 782-791.

Cox S, Limaye V, Hill C, Blumbergs P, and Roberts-Thomson P. (2010) Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis. 13: 117-124.

Dean B, Tawadros N, Scarr E, and Gibbons AS. (2010) Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. Journal of affective disorders. 120: 245-248.

Double KL, Halliday GM, Dunkley PR, Dickson PW, Gerlach M, and Riederer P. (2010) Pigmentation in the human brain and risk of Parkinson's disease. Ann Neurol. 67: 553-554.

Double KL, Reyes S, Werry EL, and Halliday GM. (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol. 92: 316-329.

Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho H-H, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, and Bush AI. (2010) Iron-Export Ferroxidase Activity of β- Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease. Cell. 142: 857-867.

Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, and Shannon Weickert C. (2010) Prefrontal GABAA receptor α-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res. 44: 673-681.

Ebneter A, Casson RJ, Wood JP, and Chidlow G. (2010) Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci. 51: 6448-6460.

Edenberg HJ, Koller DL, Xuei X, Wetherill L, McClintick JN, Almasy L, Bierut LJ, Bucholz KK, Goate A, Aliev F, Dick D, Hesselbrock V, Hinrichs A, Kramer J, Kuperman S, Nurnberger JI, Jr., Rice JP, Schuckit MA, Taylor R, Todd Webb B, Tischfield JA, Porjesz B, and Foroud T. (2010) Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res. 34: 840-852.

Elliott DA, Halliday GM, and Garner B. (2010) Apolipoprotein-E forms dimers in human frontal cortex and hippocampus. BMC Neurosci. 11: 23.

Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, and Ames D. (2010) Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 6: 291-296.

Flatscher-Bader T, Harrison E, Matsumoto I, and Wilce PA. (2010) Genes associated with alcohol abuse and tobacco smoking in the human nucleus accumbens and ventral tegmental area. Alcohol Clin Exp Res. 34: 1291-1302.

Fodero-Tavoletti MT, Villemagne VL, Paterson BM, White AR, Li QX, Camakaris J, O'Keefe G, Cappai R, Barnham KJ, and Donnelly PS. (2010) Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease. J Alzheimers Dis. 20: 49-55.

Frugier T, Morganti-Kossmann MC, O'Reilly D, and McLean CA. (2010) In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma. 27: 1-11.

Fung SJ, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, and Weickert CS. (2010) Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry. 167: 1479-1488.

Gabery S, Murphy K, Schultz K, Loy CT, McCusker E, Kirik D, Halliday G, and Petersen A. (2010) Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta neuropathologica. 120: 777-788.

Garbern JY, Neumann M, Trojanowski JQ, Lee VM, Feldman G, Norris JW, Friez MJ, Schwartz CE, Stevenson R, and Sima AA. (2010) A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain. 133: 1391-1402.

Gebhardt FM, Mitrovic AD, Gilbert DF, Vandenberg RJ, Lynch JW, and Dodd PR. (2010) Exon-skipping splice variants of excitatory amino acid transporter-2 (EAAT2) form heteromeric complexes with full-length EAAT2. The Journal of biological chemistry. 285: 31313-31324.

Gebhardt FM, Scott HA, and Dodd PR. (2010) Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue. Alzheimers Dement. 6: 465-474.

George AJ, Gordon L, Beissbarth T, Koukoulas I, Holsinger RM, Perreau V, Cappai R, Tan SS, Masters CL, Scott HS, and Li QX. (2010) A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model. Neurotox Res. 17: 360-379.

Geser F, Lee VM, and Trojanowski JQ. (2010) Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies. Neuropathology. 30: 103-112.

Gibbons AS, Thomas EA, Scarr E, and Dean B. (2010) Low density lipoprotein receptor-related protein and apolipoprotein E expression is altered in schizophrenia. Frontiers in psychiatry / Frontiers Research Foundation. 1: 19.

Gibbs ME, Maksel D, Gibbs Z, Hou X, Summers RJ, and Small DH. (2010) Memory loss caused by β-amyloid protein is rescued by a β3-adrenoceptor agonist. Neurobiol Aging. 31: 614-624.

Gorg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K, and Haussinger D. (2010) Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology. 52: 256-265.

Gowrishankar K, Steain M, Cunningham AL, Rodriguez M, Blumbergs P, Slobedman B, and Abendroth A. (2010) Characterization of the host immune response in human Ganglia after herpes zoster. J Virol. 84: 8861-8870.

Gray LJ, Dean B, Kronsbein HC, Robinson PJ, and Scarr E. (2010) Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder. Psychiatry Res. 178: 374-380.

Green A, Garrick T, Sheedy D, Blake H, Shores EA, and Harper C. (2010) The effect of moderate to heavy alcohol consumption on neuropsychological performance as measured by the repeatable battery for the assessment of neuropsychological status. Alcohol Clin Exp Res. 34: 443-450.

Guipponi M, Li QX, Hyde L, Beissbarth T, Smyth GK, Masters CL, and Scott HS. (2010) SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. J Mol Neurosci. 41: 172-182.

Haeffner F, Barnham KJ, Bush AI, and Brinck T. (2010) Generation of soluble oligomeric β-amyloid species via copper catalyzed oxidation with implications for Alzheimer's disease: a DFT study. J Mol Model. 16: 1103-1108.

Halliday GM, and McCann H. (2010) The progression of pathology in Parkinson's disease. Ann N Y Acad Sci. 1184: 188-195.

Hand A, Gray WK, Chandler BJ, and Walker RW. (2010) Sexual and relationship dysfunction in people with Parkinson's disease. Parkinsonism Relat Disord. 16: 172-176.

Hawke S, Wong TKW, Barnett M, Prineas J, and Pollard J. (2010) Multiple Sclerosis Research Australia (MSRA) Brain Bank. Mult Scler. 16: 274-275.

Hazell AS, Sheedy D, Oanea R, Aghourian M, Sun S, Jung JY, Wang D, and Wang C. (2010) Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia. 58: 148-156.

Ho AM, MacKay RK, Dodd PR, and Lewohl JM. (2010) Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics. Brain research. 1340: 1-9.

Ishiguro H, Koga M, Horiuchi Y, Noguchi E, Morikawa M, Suzuki Y, Arai M, Niizato K, Iritani S, Itokawa M, Inada T, Iwata N, Ozaki N, Ujike H, Kunugi H, Sasaki T, Takahashi M, Watanabe Y, Someya T, Kakita A, Takahashi H, Nawa H, and Arinami T. (2010) Supportive evidence for reduced expression of GNB1L in schizophrenia. Schizophr Bull. 36: 756-765.

Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y, Morikawa M, Inada T, Watanabe Y, Takahashi M, Someya T, Ujike H, Iwata N, Ozaki N, Onaivi ES, Kunugi H, Sasaki T, Itokawa M, Arai M, Niizato K, Iritani S, Naka I, Ohashi J, Kakita A, Takahashi H, Nawa H, and Arinami T. (2010) Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry. 67: 974-982.

Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Johnson LJ, Wilkins E, Field J, Danoy P, Brown MA, Rubio JP, and Butzkueven H. (2010) Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. PLoS One. 5: e10003.

Kagedal K, Kim WS, Appelqvist H, Chan S, Cheng D, Agholme L, Barnham K, McCann H, Halliday G, and Garner B. (2010) Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease. Biochim Biophys Acta. 1801: 831-838.

Kassubek J, Buttner T, Reichmann H, Riederer P, Schulz JB, Wullner U, and Csoti I. (2010) [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. Fortschr Neurol Psychiatr. 78 Suppl 1: S34-36.

Kim WS, Bhatia S, Elliott DA, Agholme L, K KAG, McCann H, Halliday GM, Barnham KJ, and Garner B. (2010) Increased ATP-binding cassette transporter A1 expression in Alzheimer's Disease hippocampal neurons. J Alzheimers Dis.

Kishigami H, Nagano S, Bush AI, and Sakoda S. (2010) Monomerized Cu, Zn-superoxide dismutase induces oxidative stress through aberrant Cu binding. Free Radic Biol Med. 48: 945-952.

Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, Lee VM, and Schellenberg GD. (2010) Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta neuropathologica. 119: 409-419.

Kryger R, and Wilce PA. (2010) The effects of alcoholism on the human basolateral amygdala. Neuroscience. 167: 361-371.

Lim S, Paterson BM, Fodero-Tavoletti MT, O'Keefe GJ, Cappai R, Barnham KJ, Villemagne VL, and Donnelly PS. (2010) A copper radiopharmaceutical for diagnostic imaging of Alzheimer's disease: a bis(thiosemicarbazonato)copper(II) complex that binds to amyloid-β plaques. Chem Commun (Camb). 46: 5437-5439.

Looi JC, Walterfang M, Styner M, Svensson L, Lindberg O, Ostberg P, Botes L, Orndahl E, Chua P, Kumar R, Velakoulis D, and Wahlund LO. (2010) Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls. Neuroimage. 51: 970-986.

Loy CT, Kril JJ, Trollor JN, Kiernan MC, Kwok JB, Vucic S, Halliday GM, and Hodges JR. (2010) The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol. 6: 175-179.

Luquin N, Yu B, Trent RJ, and Pamphlett R. (2010) DHPLC can be used to detect low-level mutations in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 11: 76-82.

Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlstrom H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, Panegyres PK, Zekanowski C, Brooks WS, Williams KL, Blair IP, Mather KA, Sachdev PS, Halliday GM, and Schofield PR. (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol. 68: 639-649.

Luu ST, Billing K, Crompton JL, Blumbergs P, Lee AW, and Chen CS. (2010) Clinicopathological correlation in pituitary gland metastasis presenting as anterior visual pathway compression. J Clin Neurosci. 17: 790-793.

Ma JF, Huang Y, Chen SD, and Halliday G. (2010) Immunohistochemical evidence for macroautophagy in neurons and endothelial cells in Alzheimer's disease. Neuropathology and applied neurobiology. 36: 312-319.

Machaalani R, Kashi PK, and Waters KA. (2010) Distribution of nicotinic acetylcholine receptor subunits α7 and β2 in the human brainstem and hippocampal formation. J Chem Neuroanat. 40: 223-231.

Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJ, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, and Mann DM. (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta neuropathologica. 119: 1-4.

McLeod MC, Scarr E, and Dean B. (2010) Effects of benzodiazepine treatment on cortical GABAA and muscarinic receptors: studies in schizophrenia and rats. Psychiatry Res. 179: 139-146.

Michel TM, Gsell W, Kasbauer L, Tatschner T, Sheldrick AJ, Neuner I, Schneider F, Grunblatt E, and Riederer P. (2010) Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study. J Alzheimers Dis. 19: 1295-1301.

Mitew S, Kirkcaldie MT, Halliday GM, Shepherd CE, Vickers JC, and Dickson TC. (2010) Focal demyelination in Alzheimer's disease and transgenic mouse models. Acta neuropathologica. 119: 567-577.

Money TT, Scarr E, Udawela M, Gibbons AS, Jeon WJ, Seo MS, and Dean B. (2010) Treating schizophrenia: novel targets for the cholinergic system. CNS Neurol Disord Drug Targets. 9: 241-256.

Murakami K, Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, and Nagai M. (2010) Dietary glycemic index is inversely associated with the risk of Parkinson's disease: a case-control study in Japan. Nutrition. 26: 515-521.

Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, and Halliday G. (2010) Missing pieces in the Parkinson's disease puzzle. Nat Med. 16: 653-661.

Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim HY, Lamberto GR, Fernandez CO, Schmid A, Chegini F, Gai WP, Chiappe D, Moniatte M, Schneider BL, Aebischer P, Eliezer D, Zweckstetter M, Masliah E, and Lashuel HA. (2010) Phosphorylation at S87 is enhanced in synucleinopathies, inhibits α-synuclein oligomerization, and influences synuclein-membrane interactions. J Neurosci. 30: 3184-3198.

Pamphlett R. (2010) Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 74: 1926; author reply 1926-1927.

Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, and Hoyer S. (2010) Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AβPP-overexpressing mice. J Alzheimers Dis. 19: 691-704.

Renshaw GM, Wise G, and Dodd PR. (2010) Ecophysiology of neuronal metabolism in transiently oxygen-depleted environments: evidence that GABA is accumulated pre-synaptically in the cerebellum. Comp Biochem Physiol A Mol Integr Physiol. 155: 486-492.

Saggu SK, Chotaliya HP, Blumbergs PC, and Casson RJ. (2010) Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study. BMC Neurosci. 11: 97.

Seidel K, Schols L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z, Dickson D, Gai WP, Bornemann A, Riess O, Rami A, Den Dunnen WF, Deller T, Rub U, and Kruger R. (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol. 67: 684-689.

Smith DG, Ciccotosto GD, Tew DJ, Perez K, Curtain CC, Boas JF, Masters CL, Cappai R, and Barnham KJ. (2010) Histidine 14 modulates membrane binding and neurotoxicity of the Alzheimer's disease amyloid-β peptide. J Alzheimers Dis. 19: 1387-1400.

Syu A, Ishiguro H, Inada T, Horiuchi Y, Tanaka S, Ishikawa M, Arai M, Itokawa M, Niizato K, Iritani S, Ozaki N, Takahashi M, Kakita A, Takahashi H, Nawa H, Keino-Masu K, Arikawa-Hirasawa E, and Arinami T. (2010) Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia. Neuropsychopharmacology. 35: 1155-1164.

Takahashi T, Wood SJ, Kawasaki Y, Suzuki M, Velakoulis D, and Pantelis C. (2010) Lack of progressive gray matter reduction of the superior temporal subregions in chronic schizophrenia. Schizophr Res. 117: 101-102.

Takahashi T, Wood SJ, Yung AR, Walterfang M, Phillips LJ, Soulsby B, Kawasaki Y, McGorry PD, Suzuki M, Velakoulis D, and Pantelis C. (2010) Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis. Br J Psychiatry. 196: 206-211.

Takahashi T, Chanen AM, Wood SJ, Yucel M, Kawasaki Y, McGorry PD, Suzuki M, Velakoulis D, and Pantelis C. (2010) Superior temporal gyrus volume in teenagers with first-presentation borderline personality disorder. Psychiatry Res. 182: 73-76.

Tang S, Machaalani R, and Waters KA. (2010) Immunolocalization of pro- and mature-brain derived neurotrophic factor (BDNF) and receptor TrkB in the human brainstem and hippocampus. Brain research. 1354: 1-14.

Taylor BV, Lucas RM, Dear K, Kilpatrick TJ, Pender MP, van der Mei IA, Chapman C, Coulthard A, Dwyer T, McMichael AJ, Valery PC, Williams D, and Ponsonby AL. (2010) Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler. 16: 398-405.

Todd G, Taylor JL, Baumann D, Butler JE, Duma SR, Hayes M, Carew-Jones F, Piguet O, Behnke S, Ridding MC, Berg D, and Double KL. (2010) Substantia nigra echomorphology and motor cortex excitability. Neuroimage. 50: 1351-1356.

Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, Ohnishi K, Ishibashi K, Teraoka R, Sakama N, Yamashita T, Nishitsuji K, Ito K, Shimada H, Lambert MP, Klein WL, and Mori H. (2010) A mouse model of amyloid β oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci. 30: 4845-4856.

Torkamani A, Dean B, Schork NJ, and Thomas EA. (2010) Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res. 20: 403-412.

Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE, Dickson DW, Rademakers R, Graff-Radford NR, Parisi JE, Petersen RC, Hatanpaa KJ, White CL, 3rd, Weiner MF, Geser F, Van Deerlin VM, Trojanowski JQ, Miller BL, Seeley WW, van der Zee J, Kumar-Singh S, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bigio EH, Deng HX, Halliday GM, Kril JJ, Munoz DG, Mann DM, Pickering-Brown SM, Doodeman V, Adamson G, Ghazi-Noori S, Fisher EM, Holton JL, Revesz T, Rossor MN, Collinge J, Mead S, and Isaacs AM. (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta neuropathologica. 120: 33-41.

Uryu K, Haddix T, Robinson J, Nakashima-Yasuda H, Lee VM, and Trojanowski JQ. (2010) Burden of neurodegenerative diseases in a cohort of medical examiner subjects*. J Forensic Sci. 55: 642-645.

Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, 3rd, Ferrer I, Llado A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, de Munain AL, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tunon MT, Martinez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, and Lee VM. (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 42: 234-239.

Villemagne VL, Pike K, Pejoska S, Boyd A, Power M, Jones G, Masters CL, and Rowe CC. (2010) 11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report. J Alzheimers Dis. 19: 423-428.

Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR, Bourgeat P, Salvado O, Bedo J, Hutton CA, Faux NG, Masters CL, and Barnham KJ. (2010) Blood-borne amyloid-β dimer correlates with clinical markers of Alzheimer's disease. J Neurosci. 30: 6315-6322.

Walker AK, Farg MA, Bye CR, McLean CA, Horne MK, and Atkin JD. (2010) Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain. 133: 105-116.

Wang YJ, Valadares D, Sun Y, Wang X, Zhong JH, Liu XH, Majd S, Chen L, Gao CY, Chen S, Lim Y, Pollard A, Aguilar E, Gai WP, Yang M, and Zhou XF. (2010) Effects of proNGF on neuronal viability, neurite growth and amyloid-β metabolism. Neurotox Res. 17: 257-267.

Weickert CS, Sheedy D, Rothmond DA, Dedova I, Fung S, Garrick T, Wong J, Harding AJ, Sivagnanansundaram S, Hunt C, Duncan C, Sundqvist N, Tsai SY, Anand J, Draganic D, and Harper C. (2010) Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry. 44: 59-70.

Werry EL, Enjeti S, Halliday GM, Sachdev PS, and Double KL. (2010) Effect of age on proliferation-regulating factors in human adult neurogenic regions. J Neurochem. 115: 956-964.

Williams DR, and Lees AJ. (2010) What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)? Mov Disord. 25: 357-362.

Wilson AJ, Carati CJ, Gannon BJ, Haberberger R, and Chataway TK. (2010) Aquaporin-1 in blood vessels of rat circumventricular organs. Cell Tissue Res. 340: 159-168.

Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, and Weickert CS. (2010) Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience. 169: 1071-1084.

Yerbury JJ, and Wilson MR. (2010) Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Aβ1-42 toxicity and uptake. Cell Stress Chaperones. 15: 115-121.

Zacest AC, Vink R, Manavis J, Sarvestani GT, and Blumbergs PC. (2010) Substance P immunoreactivity increases following human traumatic brain injury. Acta Neurochir Suppl. 106: 211-216.

Zheng L, Ishii Y, Tokunaga A, Hamashima T, Shen J, Zhao QL, Ishizawa S, Fujimori T, Nabeshima Y, Mori H, Kondo T, and Sasahara M. (2010) Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J Neurosci Res. 88: 1273-1284.